RecruitingPhase 4NCT06468202

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ohio State University
Principal Investigator
Maged Costantine, MD, MBA
Ohio State University
Intervention
Aspirin 81 mg(drug)
Enrollment
10742 target
Eligibility
14-35 years · FEMALE
Timeline
20242030

Study locations (16)

Collaborators

Patient-Centered Outcomes Research Institute · Northwestern University · Preeclampsia Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06468202 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials